2013
DOI: 10.1007/s00404-013-3060-0
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors

Abstract: Primary EOC is associated with lower TRAIL-R2 and BCL2 expression levels, while metastatic EOC is associated with higher expression of these genes. Promoter DNA methylation was not related to this finding, suggesting there are other mechanisms involved in transcriptional control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…Many of these disease states have mechanisms that are still unknown. Such an example is in ovarian serous carcinoma where high expression of TRAIL-receptor 2 (TRAIL-R2) has been associated with the disease state ( Braga et al., 2014 ). This study also showed that higher levels of Bcl2 were associated with TRAIL-R2 and the disease state.…”
Section: Bcl2 and Bcl6 Protein Deregulation And Diseasementioning
confidence: 99%
“…Many of these disease states have mechanisms that are still unknown. Such an example is in ovarian serous carcinoma where high expression of TRAIL-receptor 2 (TRAIL-R2) has been associated with the disease state ( Braga et al., 2014 ). This study also showed that higher levels of Bcl2 were associated with TRAIL-R2 and the disease state.…”
Section: Bcl2 and Bcl6 Protein Deregulation And Diseasementioning
confidence: 99%
“…Previous studies from our group described different apoptosis-related genes as EOC biomarkers associated with disease prognosis [11][12][13]. Considering that aberrant miRNAs expression plays a key pathogenic role in different stages of the carcinogenesis process and is involved in the deregulation of several biological processes, including apoptosis, miRNA profile analysis may reveal new biomarkers that can be used for EOC prognosis and chemorresistance [14].…”
Section: Introductionmentioning
confidence: 99%